The growth of digital health technologies and artificial intelligence raises novel risks, including data protection and cybersecurity risks, and key questions about the liability of services and software as a product remain unanswered. Wearables are blurring the line between consumer technology and medical devices, and consumer health data has the potential to play a significant role in future litigation. There are new mechanisms for cross-border collective actions on the horizon, an increasing trend towards consumer litigation and questions about whether or not the underlying product liability regimes are fit for purpose.
Against this backdrop, join Cooley’s international products law team on Friday 29th January 2021 for the next event in its webinar series, which will feature a cross-sector panel discussion of what these changes mean for the life sciences industry, and what risks and opportunities they present.
Topics will include:
- the product liability risks with emerging technologies
- data protection and privacy challenges – including risks of enforcement for cybersecurity issues
- experience of regulatory enforcement of digital health technologies
- what changes are on the horizon in the EU and US
- what life sciences stakeholders can do to mitigate their risks
Friday 29th January 2021
4:00 pm – 5:00 pm GMT
8:00 am – 9:00 am PT
11:00 am – 12:00 pm ET
Julia Maskell – Associate, London
Ed Turtle – Associate, London
Anne-Gabrielle Haie – Associate, Brussels
Sana Shakir – Associate, New York